Somatostatin receptor subtypes in pituitary tumors

Frontiers of Hormone Research

Volumn 20, Issue , 1996, Pages 99-107

  Greenman, Yona ^a   Melmed, Shlomo ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 54249155195     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (53)

1. Reichlin S: Somatostatin. N Engl J Med 1983;309:1495-1501.
2. Lamberts SWJ: The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocr Rev 1988;9:417-436.
3. Srikant CB, Murthy KK, Patel YC: Tissue-specific distribution of cross-linked somatostatin receptor proteins in rat. Biochem J 1992;282:339-344.
4. Leroux P, Quirion R, Pelletier G: Localization and characterization of brain somatostatin receptors as studied with somatostatin-14 and somatostatin-28 receptor autoradiography. Brain Res 1985;347:74-84.
5. Tran TV, Beal MF, Martin JB: Two types of somatostatin receptors differentiated by cyclic somatostatin analogs. Science 1985;228:492-495.
6. Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S: Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci USA 1992;89:251-255.
7. Li XJ, Forte M, North RA, Ross CA, Snyder SH: Cloning and expression of a rat somatostatin receptor enriched in brain. J Biol Chem 1992;30:21307-21312.
8. Kluxen FW, Bruns C, Lübbert H: Expression cloning of a rat brain somatostatin receptor cDNA. Proc Natl Acad Sci USA 1992;89:4618-4622.
9. Yamada Y, Reisine T, Law SF, et al: Somatostatin receptors, an expanding gene family: Cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol Endocrinol 1992;6:2136-2142.
10. Meyerhof W, Wulfsen I, Schönrock C, Fehr S, Richter D: Molecular cloning of a somatostatin-28 receptor and comparison of its expression pattern with that of a somatostatin-14 receptor in rat brain. Proc Natl Acad Sci USA 1992;89:10267-10271.
11. Rohrer L, Raulf F, Bruns C, Buettner R, Hofstaedter F, Schüle R: Cloning and characterization of a forth human somatostatin receptor. Proc Natl Acad Sci USA 1993;90:4196-4200.
12. Bruno JF, Xu Y, Song J, Berelowitz M: Molecular cloning and functional expression of a brain-specific somatostatin receptor. Proc Natl Acad Sci USA 1992;89:11151-11155.
13. Yamada Y, Kagimoto S, Kubota A, et al: Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochem Biophys Res Commun 1993;195:844-852.
14. O'Carroll AM, Lolait SJ, König M, Mahan LC: Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28. Mol Pharmacol 1992;42:939-946.
15. James RA, Weightman DR: Somatostatin receptors: Types and classification in the pituitary. Endocrinologist 1995;5:55-60.
16. Vanneti M, Kouba M, Wang X, Vogt G, Hollt V: Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett 1992;311:290-294.
17. Patel YC, Greenwood M, Kent G, Panetta R, Srikant CB: Multiple gene transcripts of the somatostatin receptor SSTR2: Tissue selective distribution and cAMP regulation. Biochem Biophys Res Commun 1993;192:288-294.
18. Raynor K, O'Carrol AM, Kong H, et al: Characterization of cloned somatostatin receptors SSTR4 and SSTR5. Mol Pharmacol 1993;44:385-392.
19. Raynor K, Murphy WA, Coly CH, et al: Cloned somatostatin receptors: Identification of subtype-selective peptides and demonstration of high affinity of linear peptides. Mol Pharmacol 1993;43:838-844.
20. Rens-Domiano S, Law SF, Yamada Y, Seino S, Bell GI, Reisine T: Pharmacological properties of two cloned somatostatin receptors. Mol Pharmacol 1992;42:28-34.
21. Patel YC, Greenwood MT, Warszynska A, Panetta R, Srikant CB: All five human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase. Biochem Biophys Res Commun 1994;198:605-612.
22. Vanetti M, Vogt G, Hollt V: The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization. FEBS Lett 1993;331:260-266.
23. Hou C, Gilbert RL, Barber DL: Sub-type specific signalling mechanisms of somatostatin receptors SSTR1 and SSTR2. J Biol Chem 1994;269:10357-10362.
24. Buscail L, Delesque N, Estève JP, et al: Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogs: Mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci USA 1994;91:2315-2319.
25. Florio T, Rim C, Hershberger RE, Loda M, Stork PJS: The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells. Mol Endocrinol 1994;8:1289-1297.
26. Bito H, Mori M, Sakanada C, et al: Functional coupling of SSTR4. a major hippocampal somatostatin receptor, to adenylate cyclase inhibition, arachidonate release, and activation of the mitogen-activated protein kinase cascade. J Biol Chem 1994;269:12722-12730.
27. Bruno JF, Xu J, Song J, Berrelowitz M: Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology 1993;133:2561-2567.
28. Reubi JC, Landolt AM: High density of somatostatin receptors in pituitary tumors from acromegalic patients. J Clin Endocrinol Metab 1984;59:1148-1151.
29. Ikuyama S, Nawata H, Kato K, Karashima T, Ibayashi H, Nakagaki H: Specific somatostatin receptors on human pituitary adenoma cell membranes. J Clin Endocrinol Metab 1985;61:666-671.
30. Moyse E, Le Dafniet M, Epelbaum J, et al: Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas. J Clin Endocrinol Metab 1985;61:98-103.
31. Reubi JC, Heitz PU, Landolt AM: Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses. J Clin Endocrinol Metab 1987;65:65-73.
32. Bertherat J, Brue T, Enjalbert A, et al: Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions. J Clin Endocrinol Metab 1992;75:540-546.
33. Ur E, Mather SJ, Bomangi J, et al: Pituitary imaging using a labeled somatostatin analog in acromegaly. Clin Endocrinol 1992;36:147-150.
34. de Bruin TWA, Kwekkeboom DJ, Van't Verlaat JW, et al: Clinically non-functioning pituitary adenomas and octreotide response to long term high dose treatment, and studies in vitro. J Clin Endocrinol Metab 1992;75:1310-1317.
35. 123I] SDZ 204-090). J Clin Endocrinol Metab 1991;73:850-856.
36. Morel G, Leroux P, Pelletier G: Ultrastructural autoradiographic localization of somatostatin-28 in the rat pituitary gland. Endocrinology 1985;116:1615-1620.
37. Raynor K, Reisine T: Subtypes of somatostatin receptors are expressed in the anterior pituitary cell line GH3. J Pharmacol Exp Ther 1993;264:110-116.
38. Greenman Y, Melmed S: Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. J Clin Endocrinol Metab 1994;78:398-403.
39. Greenman Y, Melmed S: Expression of three somatostatin receptor subtypes in pituitary adenomas: Evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J Clin Endocrinol Metab 1994;79:724-729.
40. Miller GM, Alexander JM, Bikkal HA, Katznelson L, Zervas NT, Klibanski A: Somatostatin receptor subtype expression in pituitary adenomas. J Clin Endocrinol Metab 1995;80:1386-1392.
41. Reubi JC, Schaer JC, Waser B, Mengod C: Expression and localization of somatostatin receptor SSTR1, SSTR2 and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res 1994;54:3455-3459.
42. Panetta R, Patel YC: Expression of mRNAs for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors. Life Sci 1995;56:333-342.
43. Thomas F, Labat-Moleur F, Blumbergtick J, Friedmann A: Transcription of somatostatin receptor subtypes 1, 2 and 3 genes in human pituitary tumors. Analysis by two distinct semiquantitative reverse transcriplion-polymerase chain reaction methods. Proc 75th Annu Meet Endocr Soc, 1993. p 671.
44. Katznelson L, Oppenheim DS, Coughlin JF, Kliman B, Schoenfeld DA, Klibanski A: Chronic somatostatin analog administration in patients with a-subunit-sccreting pituitary tumors. J Clin Endocrinol Metab 1992;75:1318-1325.
45. Lamberts SWJ, Krenning EP, Reubi JC: The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 1991:12:450-482.
46. de Herder WW, Krenning EP, Malchoff CD, et al: Somatostatin receptor scintigraphy: Its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or cotricotropin-releasing hormone secretion. Am J Med 1994;96:305-312.
47. Ezzat S, Snyder PJ, Young WF, et al: Octreotide treatment of acromegaly. A randomized, multicenter study. Ann Intern Med 1992;117:711-718.
48. Sassolas G, Harris AG, James-Deidier A: French SMS 201-995 Acromegaly Study Group: Long term effects of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients. J Clin Endocrinol Metab 1990;71:391-392.
49. Reubi JC, Landolt AM: The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status. J Clin Endocrinol Metab 1989;68:844-850.
50. Ikuyama H, Nawata H, Kato KI, Ibayashi H, Nakagaki H: Plasma growth hormone responses to somatostatin (SRIH) and SRIH receptors in pituitary adenomas in acromegalic patients. J Clin Endocrinol Metab 1986;62:729-733.
51. Kelijman M, Williams TC, Downs TR, Frohman LA: Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly. J Clin Endocrinol Metab 1988;67:958-963.
52. Bertherat J, Chanson P, Dewailly D, Dupuy M, Jaquet P, Peillon F, Epelbaum J: Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas. J Clin Endocrinol Metab 1993;77:1577-1583.
53. Plöckinger U, Reichel M, Fett U, Saeger W, Quabbe HJ: Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: Effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy. J Clin Endocrinol Metab 1994;79:1416-1423.